This Biomarker Predicts Survival in Autoimmune Lung Disease
(MedPage Today) -- One major subgroup of patients with interstitial lung disease (ILD) arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news
More News: Autoimmune Disease | Dermatology | Dermatomyositis | Interstitial Lung Disease | Polymyositis | Rheumatology